TY  - GEN
AU  - Douglas,Alexander D
AU  - Williams,Andrew R
AU  - Illingworth,Joseph J
AU  - Kamuyu,Gathoni
AU  - Biswas,Sumi
AU  - Goodman,Anna L
AU  - Wyllie,David H
AU  - Crosnier,Cécile
AU  - Miura,Kazutoyo
AU  - Wright,Gavin J
AU  - Long,Carole A
AU  - Osier,Faith H
AU  - Marsh,Kevin
AU  - Turner,Alison V
AU  - Hill,Adrian V S
AU  - Draper,Simon J
TI  - The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody
SN  - 2041-1723
PY  - 2012///0402
KW  - Adenoviridae
KW  - Animals
KW  - Antibodies, Neutralizing
KW  - biosynthesis
KW  - Antibodies, Protozoan
KW  - Antigens, Protozoan
KW  - immunology
KW  - Carrier Proteins
KW  - antagonists & inhibitors
KW  - Cross Protection
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Erythrocytes
KW  - Escherichia coli
KW  - Genetic Vectors
KW  - Humans
KW  - Malaria Vaccines
KW  - administration & dosage
KW  - Malaria, Falciparum
KW  - blood
KW  - Merozoites
KW  - drug effects
KW  - Mice
KW  - Plasmids
KW  - Plasmodium falciparum
KW  - Rabbits
KW  - Recombinant Proteins
KW  - genetics
KW  - Vaccination
N1  - Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/ncomms1615
ER  -